Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis
ThrombUS+ is a €9.5 million project funded by the European Commission focusing on early diagnosis and prevention of deep vein thrombosis (DVT) of the lower limbs, a common and life-threatening condition.
Our goal is to create a groundbreaking smart wearable device that will bring together the latest technologies of the different partners to continuously and autonomously monitor the lower limbs to detect clot formation, estimate the risk of thrombosis and create early alerts.
This device will use autonomous AI-driven DVT detection and combine wearable ultrasound hardware, impedance plethysmography, and light reflection rheography to quickly detect blood clots.
In addition, it will also continuously measure activity and physiological data to assess the risk of DVT and support prevention through serious gaming.
ThrombUS+ device will be suitable for postoperative patients, those undergoing lengthy surgical procedures, cancer patients, bedridden individuals at home or in care units, and women during pregnancy and postpartum.
ThrombUS+ will use large datasets from three clinical studies for AI training. One early feasibility study and one multi-centre clinical trial will validate the results.